Identification and treatment of implantable cardioversion defibrillator with psychological diseases

doi:10.3877/cma.j.issn.2095-6568.2024.01.009

Chinese Journal of Heart and Heart Rhythm(Electronic Edition) ›› 2024, Vol. 12 ›› Issue (01): 42-44. doi: 10.3877/cma.j.issn.2095-6568.2024.01.009

• Forum of Heart and Psychology • Previous Articles

Identification and treatment of implantable cardioversion defibrillator with psychological diseases

Hongmei Zhou¹, Jianying Sun², Ruogu Li³, Tianbao Yao¹, Peng Nie¹, Jun Bu¹, Meng Jiang¹, Jialiang Mao¹^,^†()

^1. Department of Cardiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China
^2. Medical Psychology Department, Shanghai Armed Police Corps Hospital, Shanghai 201103, China
^3. Department of Cardiology, Shanghai Chest Hospital, Shanghai 200030, China

Received:2023-06-05 Online:2024-03-25 Published:2024-04-10
Contact: Jialiang Mao

Abstract

Hongmei Zhou, Jianying Sun, Ruogu Li, Tianbao Yao, Peng Nie, Jun Bu, Meng Jiang, Jialiang Mao. Identification and treatment of implantable cardioversion defibrillator with psychological diseases[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2024, 12(01): 42-44.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxzyxldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-6568.2024.01.009

https://zhxzyxldzzz.cma-cmc.com.cn/EN/Y2024/V12/I01/42

Figures/Tables 2

References 7

[1]	Pedersen SS, Hoogwegt MT, Jordaens L, et al. Relation of symptomatic heart failure and psychological status to persistent depression in patients with implantable cardioverter-defibrillator[J]. Am J Cardiol, 2011, 108(1):69-74.
[2]	Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review[J]. Heart Fail Clin, 2011, 7(1):59-68.
[3]	中国康复医学会心血管病预防与康复专业委员会, 中国老年学学会心血管病专业委员会, 中华医学会心身医学分会. 在心血管科就诊患者心理处方中国专家共识(2020版)[J]. 中华内科杂志, 2020, 59(10):764-771.
[4]	庄琦, 毛家亮, 李春波, 等. 躯体化症状自评量表的初步编制及信度和效度研究[J]. 中华行为医学与脑科学杂志, 2010, 19(9):847-849.
[5]	胡大一,于欣,孙学礼,等. 双心医学[M].北京:中国协和医科大学出版社,2006.
[6]	Jiang M, Zhang W, Su X, et al. Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China (SSS-CN): a research protocol for a diagnostic study[J]. BMJ Open, 2019, 9(9):e024290.
[7]	李广平. 海河心脏病学理论与临床[M].天津:科学出版社,2020.

随访时间	SSS	PHQ-9	所用药物
2019.01.24	46	8	舍曲林50 mg＋曲唑酮50 mg
2019.02.14	53	7	舍曲林50 mg＋曲唑酮50 mg
2019.03.07	44	2	舍曲林50 mg＋曲唑酮50 mg消化道不适，临时增加舒必利100 mg，每日2次
2019.04.04	33	0	舍曲林50 mg＋曲唑酮50 mg
2019.08.22	24	0	舍曲林50 mg＋曲唑酮50 mg
2020.01.16	20	0	舍曲林50 mg＋曲唑酮25 mg

随访时间	SSS	PHQ-9	所用药物
2019.01.24	46	8	舍曲林50 mg＋曲唑酮50 mg
2019.02.14	53	7	舍曲林50 mg＋曲唑酮50 mg
2019.03.07	44	2	舍曲林50 mg＋曲唑酮50 mg消化道不适，临时增加舒必利100 mg，每日2次
2019.04.04	33	0	舍曲林50 mg＋曲唑酮50 mg
2019.08.22	24	0	舍曲林50 mg＋曲唑酮50 mg
2020.01.16	20	0	舍曲林50 mg＋曲唑酮25 mg

随访时间	SSS	PHQ-9	GAD-7	所用药物
2021.12.28	38	3	3	舍曲林50 mg＋阿戈美拉汀12.5 mg
2021.01.13	35	3	4	舍曲林50 mg＋阿戈美拉汀12.5 mg
2021.03.03	23	0	0	开始停用舍曲林及阿戈美拉汀

随访时间	SSS	PHQ-9	GAD-7	所用药物
2021.12.28	38	3	3	舍曲林50 mg＋阿戈美拉汀12.5 mg
2021.01.13	35	3	4	舍曲林50 mg＋阿戈美拉汀12.5 mg
2021.03.03	23	0	0	开始停用舍曲林及阿戈美拉汀

Please choose a citation manager

Content to export

Identification and treatment of implantable cardioversion defibrillator with psychological diseases

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 7

Related Articles 0

Recommended Articles

Metrics

Comments

模态框（Modal）标题

Please choose a citation manager

Content to export

Identification and treatment of implantable cardioversion defibrillator with psychological diseases

RichHTML

PDF (PC)

Knowledge

Cited

Abstract

Cite this article

share this article

Figures/Tables 2

References 7

Related Articles 0

Recommended Articles

Metrics

Comments